The goal of this study is to determine the safety and tolerability of orally taken probiotic
(R-2487) in patients with Rheumatoid Arthritis.
Patients will take an oral dosage of probiotic (R-2487) and physicians will assess and
measure their Rheumatoid Arthritis. Blood and fecal evaluations of inflammation and
assessment of probiotic (R-2487) on fecal level will also be measured.